ImCheck Therapeutics
ImCheck Therapeutics is a developer of immunomodulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric and ovarian cancer cells, and other solid tumors.
Domain
imchecktherapeutics.com
Country
FranceIndustry
BiopharmaEmployees
11-50
Last Funding
$22.4M
Founded
2014
Tech Stack (15 technologies)
Frequently Asked Questions
What technologies does ImCheck Therapeutics use?+
ImCheck Therapeutics uses 15 technologies including Bootstrap, cdnjs, Google Analytics.
What industry is ImCheck Therapeutics in?+
ImCheck Therapeutics operates in the Biopharma industry.
Where is ImCheck Therapeutics based?+
ImCheck Therapeutics is headquartered in France.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026